BioNexus Gene Lab Corp Annual Net Income (Loss) Attributable to Parent in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
BioNexus Gene Lab Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to 2024.
  • BioNexus Gene Lab Corp Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$348K, a 213% decline year-over-year.
  • BioNexus Gene Lab Corp Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$1.6M, a 39.2% increase year-over-year.
  • BioNexus Gene Lab Corp annual Net Income (Loss) Attributable to Parent for 2024 was -$1.6M, a 39.2% increase from 2023.
  • BioNexus Gene Lab Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$2.63M, a 639% decline from 2022.
  • BioNexus Gene Lab Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$356K, a 147% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1.6M +$1.03M +39.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-15
2023 -$2.63M -$2.27M -639% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-15
2022 -$356K -$1.11M -147% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 $752K -$343K -31.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $1.09M +$1.34M Jan 1, 2020 Dec 31, 2020 10-K 2022-04-06
2019 -$246K -$273K -1032% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 $26.5K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.